Efficacy and immune mechanism of QingfeiTongluo prescriptions intervention on Mycoplasma pneumoniae pneumonia in childre

Phase 1

Recruiting

• Conditions: Mycoplasma pneumoniae pneumonia

• Registration Number: ITMCTR1900002750
• Lead Sponsor: Tianjin Nankai Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients with Mycoplasma pneumoniae pneumonia or refractory Mycoplasma pneumoniae pneumonia;
2. Aged 6-16 years;
3. Parents signed informed consent.

Exclusion Criteria

1. With severe active infection or serious heart, liver, kidney and hematopoietic system diseases, or other basic diseases.
2. The withdrawal time of other clinical trial drugs is less than 4 weeks.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
curative effect;